European Commission Grants Orphan Medicinal Product Designation to Karyopharm and Menarini Group

The European Commission has granted Orphan Medicinal Product Designation to Karyopharm Therapeutics Inc., a pharmaceutical company pioneering cancer therapies, and Menarini Group, a leading international pharmaceutical company, for selinexor used to treat myelofibrosis (MF). Selinexor was granted the orphan drug designation by the US Food and Drug Administration (FDA) in May 2022. Selinexor is currently […]

Continue Reading

US FDA Announced, Blood Pressure Medicine Recalled Due to Potential Cancer Risk

The US Food and Drug Administration (FDA), announced that the pharmaceutical company Aurobindo Pharma is recalling a blood pressure medication because of a potential cancer risk. The company is recalling two lots of quinapril and hydrochlorothiazide tablets because of the levels of nitrosamine. The tablets are most commonly prescribed for the treatment of hypertension to […]

Continue Reading